• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females.非酒精性脂肪性肝病的危险因素构成在男性和女性中随体重指数而变化。
Oncotarget. 2016 Jun 14;7(24):35632-35642. doi: 10.18632/oncotarget.9691.
2
A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.素食不能预防非酒精性脂肪性肝病(NAFLD):佛教僧侣与普通人群的横断面研究
Turk J Gastroenterol. 2015 Jul;26(4):336-43. doi: 10.5152/tjg.2015.0046. Epub 2015 Jun 2.
3
Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.年龄在 45-60 岁的中国人群中,非酒精性脂肪肝与高血压之间的相关性存在性别差异。
Clin Exp Hypertens. 2016;38(7):639-643. doi: 10.1080/10641963.2016.1182181. Epub 2016 Sep 28.
4
Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.中国人群非酒精性脂肪性肝病的患病率及危险因素:一项8年随访研究
World J Gastroenterol. 2016 Apr 7;22(13):3663-9. doi: 10.3748/wjg.v22.i13.3663.
5
Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.学龄儿童非酒精性脂肪性肝病的患病率、危险因素及预测因素:埃及亚历山大市一项基于医院的研究
Arab J Gastroenterol. 2014 Jun;15(2):76-81. doi: 10.1016/j.ajg.2014.05.002. Epub 2014 Jul 10.
6
Prevalence and associated metabolic factors of fatty liver disease in the elderly.老年人脂肪肝的患病率及相关代谢因素。
Exp Gerontol. 2013 Aug;48(8):705-9. doi: 10.1016/j.exger.2013.05.059. Epub 2013 May 27.
7
The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study.维生素 D 不足与非酒精性脂肪肝病的关系:一项基于人群的研究。
Nutrients. 2017 Jul 27;9(8):806. doi: 10.3390/nu9080806.
8
The Symptoms of Gastroesophageal Reflux Disease Correlate with High Body Mass Index, the Aspartate Aminotransferase/Alanine Aminotransferase Ratio and Insulin Resistance in Japanese Patients with Non-alcoholic Fatty Liver Disease.日本非酒精性脂肪性肝病患者的胃食管反流病症状与高体重指数、天冬氨酸氨基转移酶/丙氨酸氨基转移酶比值及胰岛素抵抗相关。
Intern Med. 2015;54(24):3099-104. doi: 10.2169/internalmedicine.54.4297. Epub 2015 Dec 15.
9
Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.不同年龄和体重指数女性非酒精性脂肪性肝病及其代谢危险因素的患病率
Menopause. 2015 Jun;22(6):667-73. doi: 10.1097/GME.0000000000000352.
10
Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome.轻度饮酒对生活方式相关疾病的影响:日本代谢综合征女性脂肪肝伴肝酶升高的预测因素。
BMC Gastroenterol. 2016 Feb 18;16:17. doi: 10.1186/s12876-016-0431-6.

引用本文的文献

1
Integrated liver-secreted and plasma proteomics identify a predictive model that stratifies MASH.整合肝脏分泌蛋白质组学和血浆蛋白质组学鉴定出一种对非酒精性脂肪性肝炎进行分层的预测模型。
Cell Rep Med. 2025 May 20;6(5):102085. doi: 10.1016/j.xcrm.2025.102085. Epub 2025 Apr 17.
2
Racial Disparities in Mortality Rates among Patients with Hepatic Steatosis, Non-Alcoholic Fatty Liver Disease, and Non-Alcoholic Steatohepatitis: Insights from NHANES III Data.肝脂肪变性、非酒精性脂肪性肝病和非酒精性脂肪性肝炎患者死亡率的种族差异:来自美国国家健康和营养检查调查(NHANES)III数据的见解
J Racial Ethn Health Disparities. 2025 Mar 4. doi: 10.1007/s40615-025-02317-9.
3
The relationship between anthropometric indices and non-alcoholic fatty liver disease in adults: a cross-sectional study.成人人体测量指标与非酒精性脂肪性肝病的关系:一项横断面研究。
Front Nutr. 2025 Jan 7;11:1494497. doi: 10.3389/fnut.2024.1494497. eCollection 2024.
4
Epidemiology of lean/non-obese nonalcoholic fatty liver disease in China: A systematic review and meta-analysis.中国非肥胖/非酒精性脂肪性肝病的流行病学:系统评价和荟萃分析。
Saudi Med J. 2023 Sep;44(9):848-863. doi: 10.15537/smj.2023.44.9.20230021.
5
Sarcopenia as a Predictive Factor for Recurrence of Hepatocellular Carcinoma Following Radiofrequency Ablation.肌肉减少症作为射频消融术后肝细胞癌复发的预测因素。
Asian Pac J Cancer Prev. 2023 Apr 1;24(4):1143-1150. doi: 10.31557/APJCP.2023.24.4.1143.
6
Epidemiology and prevalence of lean nonalcoholic fatty liver disease and associated cirrhosis, hepatocellular carcinoma, and cardiovascular outcomes in the United States: a population-based study and review of literature.美国瘦型非酒精性脂肪性肝病及其相关肝硬化、肝细胞癌和心血管结局的流行病学和流行率:一项基于人群的研究和文献复习。
J Gastroenterol Hepatol. 2023 Feb;38(2):269-273. doi: 10.1111/jgh.16049. Epub 2022 Nov 16.
7
Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病的正常体重和肥胖个体的临床及实验室特征
Diagnostics (Basel). 2022 Mar 24;12(4):801. doi: 10.3390/diagnostics12040801.
8
NAFLD in normal weight individuals.正常体重个体中的非酒精性脂肪性肝病
Diabetol Metab Syndr. 2022 Mar 24;14(1):45. doi: 10.1186/s13098-022-00814-z.
9
Ultrasonographic Features Associated with Diffuse Hepatosteatosis among Diabetic Obese and Normal Body Mass Index Patients.糖尿病肥胖患者和正常体重指数患者中与弥漫性肝脂肪变性相关的超声特征
J Med Ultrasound. 2020 May 18;28(4):235-238. doi: 10.4103/JMU.JMU_94_19. eCollection 2020 Oct-Dec.
10
Rescue of Hepatic Phospholipid Remodeling Defectin iPLA2β-Null Mice Attenuates Obese but Not Non-Obese Fatty Liver.iPLA2β 基因敲除小鼠的肝磷脂重塑缺陷挽救减轻肥胖型但不减轻非肥胖型脂肪肝。
Biomolecules. 2020 Sep 17;10(9):1332. doi: 10.3390/biom10091332.

本文引用的文献

1
Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back.高尿酸血症与非酒精性脂肪性肝病:从临床到基础再回到临床。
Hepatol Int. 2016 Mar;10(2):286-93. doi: 10.1007/s12072-015-9682-5. Epub 2015 Dec 15.
2
Nonalcoholic fatty liver disease: a systematic review.非酒精性脂肪性肝病:系统评价。
JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370.
3
Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes?非酒精性脂肪性肝病中的生物标志物——皇帝没穿衣服?
World J Gastroenterol. 2015 Mar 21;21(11):3223-31. doi: 10.3748/wjg.v21.i11.3223.
4
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病
BMJ. 2014 Jul 29;349:g4596. doi: 10.1136/bmj.g4596.
5
Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic.非酒精性脂肪性肝病:对日益流行疾病的全面综述
World J Gastroenterol. 2014 Sep 14;20(34):12082-101. doi: 10.3748/wjg.v20.i34.12082.
6
Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment.非酒精性脂肪性肝病:流行病学、临床病程、检查及治疗。
Dtsch Arztebl Int. 2014 Jun 27;111(26):447-52. doi: 10.3238/arztebl.2014.0447.
7
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.非酒精性脂肪肝与非酒精性脂肪性肝炎的纤维化进展:配对活检研究的系统评价和荟萃分析
Clin Gastroenterol Hepatol. 2015 Apr;13(4):643-54.e1-9; quiz e39-40. doi: 10.1016/j.cgh.2014.04.014. Epub 2014 Apr 24.
8
Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population.非酒精性脂肪性肝病、代谢综合征与普通人群亚临床心血管改变。
Heart. 2014 Jun;100(12):938-43. doi: 10.1136/heartjnl-2013-305099. Epub 2014 Apr 10.
9
Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease.脂蛋白代谢、血脂异常与非酒精性脂肪性肝病。
Semin Liver Dis. 2013 Nov;33(4):380-8. doi: 10.1055/s-0033-1358519. Epub 2013 Nov 12.
10
Noninvasive evaluation of NAFLD.非酒精性脂肪性肝病的无创评估。
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):666-75. doi: 10.1038/nrgastro.2013.175. Epub 2013 Sep 24.

非酒精性脂肪性肝病的危险因素构成在男性和女性中随体重指数而变化。

Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females.

作者信息

Wang Long, Guo Jinghui, Lu Jianping

机构信息

Department of Gastroenterology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

Health Examination Center, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

出版信息

Oncotarget. 2016 Jun 14;7(24):35632-35642. doi: 10.18632/oncotarget.9691.

DOI:10.18632/oncotarget.9691
PMID:27248665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5094950/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and correlated with obesity. To evaluate the role of body mass index (BMI) and gender difference in NAFLD, 8817 general adult subjects underwent physical examinations and were divided into four groups: underweight, normal, overweight and obese. The risk factor compositions for NAFLD were evaluated in each group by gender. The percentage of subjects with NAFLD increased sharply from 0.4% in the underweight group up to 81.9 % in the obese group. BMI stratification showed distinct risk factor compositions associated with NAFLD in males and females according to BMI and improved the performance of NAFLD prediction models in each group. Triglycerides (TG), alanine transaminase (ALT), aspartate transaminase (AST), and uric acid were steady risk factors for NAFLD in males. Total cholesterol (TC), TG, low-density lipoprotein cholesterol (LDL-C), ALT, and uric acid were steady risk factors for NAFLD in females. TG, ALT and uric acid were common risk factors in both genders with high performance for NAFLD discrimination. Our data provide gender- and BMI-specific risk factor compositions that will facilitate individualised treatment and benefit NAFLD control and prevention.

摘要

非酒精性脂肪性肝病(NAFLD)非常普遍,且与肥胖相关。为了评估体重指数(BMI)和性别差异在NAFLD中的作用,8817名成年普通受试者接受了体格检查,并被分为四组:体重过轻、正常、超重和肥胖。按性别对每组中NAFLD的危险因素构成进行了评估。NAFLD受试者的百分比从体重过轻组的0.4%急剧上升至肥胖组的81.9%。BMI分层显示,根据BMI,男性和女性与NAFLD相关的危险因素构成不同,且改善了每组中NAFLD预测模型的性能。甘油三酯(TG)、丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)和尿酸是男性NAFLD的稳定危险因素。总胆固醇(TC)、TG、低密度脂蛋白胆固醇(LDL-C)、ALT和尿酸是女性NAFLD的稳定危险因素。TG、ALT和尿酸是两性中对NAFLD鉴别具有高效能的常见危险因素。我们的数据提供了按性别和BMI区分的危险因素构成,这将有助于个体化治疗,并有利于NAFLD的控制和预防。